Summary

UAE respiratory care devices market is anticipated to register growth with an impressive CAGR in the forecast period, 2023-2027, on the account of increasing instances of respiratory diseases. Majorly the market is driven due to the increasing population complaining about the lack of breath, suffering from breathing issues due to pulmonary diseases or disorders, etc. Also, the increasing geriatric population in the country is expected to drive the growth of the UAE respiratory care devices market in the upcoming five years. Surging investments in product development, through research and innovative product development further facilitate the growth of the UAE respiratory care devices market in the next five years.
Respiratory care devices are the medical devices that are utilized for the diagnosis, and treatment of respiratory diseases & failures, and for monitoring the conditions of patients suffering from breathing issues. The devices also include precautionary products masks, etc. that can be categorized as consumables that although not mechanical aids the breathing process in case of excessive pollution or a heavy air environment.
Pulmonary Diseases Drive Market Growth
Increasing instances of respiratory & pulmonary diseases among the population of the United Arab Emirates majorly drive the growth of the UAE respiratory care devices market in the upcoming five years. In 2017, over 19,742 people in UAE suffered from chronic obtrusive pulmonary disease (COPD). Also, diseases like asthma, chronic bronchitis, pulmonary hypertension, pneumonia, and lung cancer are further aiding the increasing population suffering from pulmonary diseases and thus the demand for respiratory care devices is multiplying and aiding the market growth.
Factors like increasing pollution in the environment due to exhaust from automotive, industries, etc., genetic respiratory infections, occupational chemical exposure, and increasing consumption of tobacco products like smoking, all lead to increasing pulmonary disorders thereby indirectly affecting the growth of the UAE respiratory care devices market in the future five years.
Prevalence of Lung Cancer Supports Demand
Increasing cases of lung cancer among the population also drives the growth of the UAE respiratory care devices market in the upcoming five years. Surging demand for diagnostic devices due to rapidly increasing new cases of lung cancer facilitates market growth. In the year 2020, over 226 new lung cancer cases were discovered, therefore establishing the high demand for early diagnostic and efficient medical devices such that timely diagnosis may guarantee successful treatment procedures.
Early diagnosis of cancer is important for effective therapeutic processes like radiotherapy, chemotherapy, surgical treatments, etc. Late-stage cancer diagnosis leaves no time for treatment and often leads to death due to the excessive spread of cancer in the body. In the year 2020, about 187 deaths were recorded due to lung cancer in the UAE. The increasing mortality rate due to lung cancer is an alarming concern for the government which is further investing financially as well as providing favorable schemes to promote the production & utilization of respiratory care devices, thus aiding the growth of the UAE respiratory care devices market in the next five years.
Market Segmentation
The UAE respiratory care devices market is segmented by product type, indication, end user, competitive landscape, and regional distribution. Based on product type, the market is further segmented into therapeutic devices, monitoring devices, diagnostic devices, consumables & accessories. Therapeutic devices include ventilators, pap devices, nebulizers, oxygen concentrators, humidifiers, inhalers, and others. Monitoring devices include pulse oximeters, gas analyzers, and capnography. Diagnostic devices include spirometers, peak flow meters, and polysomnography (PSG) devices. Consumables and accessories include masks, breathing circuits, disposable resuscitators, and others. By indication, the market is further bifurcated into chronic obstructive pulmonary disease, sleep apnea, asthma, infectious diseases, and others. Based on end users, the market is fragmented into hospitals & clinics, ambulatory care centers, and others. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Abu Dhabi region, Dubai region, Sharjah region, and the Rest of UAE.
Company Profile
GE Healthcare UAE, Philips Healthcare Middle East, Medtronic, UAE, Invacare Corporation UAE, ResMed UAE, Dräger UAE, Getinge Group Middle East FZ-LLC, Becton, Dickinson, and Company UAE, among others is a partial list of major market players of the companies responsible for the growth of UAE respiratory care devices market.
Report Scope:
In this report, UAE respiratory care devices market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• UAE Respiratory Care Devices Market, By Product Type:
o Therapeutic Devices
 Ventilators
 Pap Devices
 Nebulizers
 Oxygen Concentrators
 Humidifiers
 Inhalers
 Others
o Monitoring Devices
 Pulse Oximeters
 Gas Analyzers
 Capnography
o Diagnostic Devices
 Spirometers
 Peak Flow Meters
 Polysomnography (PSG) Devices
o Consumables & Accessories
 Masks
 Breathing Circuits
 Disposable Resuscitators
 Others
• UAE Respiratory Care Devices Market, By Indication:
o Chronic Obstructive Pulmonary Disease
o Sleep Apnea
o Asthma
o Infectious Diseases
o Others
• UAE Respiratory Care Devices Market, By End User:
o Hospitals & Clinics
o Ambulatory Care Centers
o Others
• UAE Respiratory Care Devices Market, By Region:
o Abu Dhabi
o Dubai
o Sharjah
o Rest of UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in UAE respiratory care devices market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents